Ligand Pharmaceuticals | LGND - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
Agenus USD 14.67M 1.35M 2026-03
Amgen USD 95.64B 94.98B 2026-06
Anika Therapeutics 183.47M 4.09M 2026-06
Arrowhead Research USD 24.56M 716K 2026-06
Baxter International USD 78M 20M 2026-03
Bristol-Myers Squibb USD 407M 4M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Enviri Corporation USD 28.44M 1.74M 2025-12
Gilead Sciences USD 247M 7M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
Glaxosmithkline GBP 192.73M 14.79M 2026-03
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 18.84M 1.24M 2026-06
Intrexon USD 2K 5K 2024-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
MacroGenics USD 4.89M 1.55M 2026-03
Merck USD 525M 46M 2026-06
Pacira USD 3.62M 77K 2026-06
Pfizer USD 667M 4M 2026-06
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Veracyte USD 2K 1000 2023-12